Literature DB >> 7470846

Distribution of cerebral lesions in acquired hepatocerebral degeneration.

M H Finlayson, B Superville.   

Abstract

The brain lesions of our patients with chronic portal-systemic venous shunts were much the same regardless of the presence or absence of primary liver disease. Alzheimer's type 2 abnormality of astrocytes and demarcated areas of spongy degeneration were found, mainly in the grey matter, with more severe involvement of the basal ganglia and the deeper layers of the frontal, parietal and occipital cortex. The spongy degeneration showed an especially close correlation with the arterial blood supply, being greatest in borderland areas that fall between the regions usually supplied by one or other of the major cerebral arteries. Previous investigations have not been primarily concerned with selective vulnerability so that comparisons are difficult, but on review, there is evidence that this pattern of involvement is a feature of both Wilson's disease and acquired hepatocerebral degeneration. The toxic effect of the portal blood is greatest in the grey matter, probably because of the greater metabolic activity there, and the distribution of lesions within this area of greater vulnerability appears to be further influenced by circulatory factors.

Entities:  

Mesh:

Year:  1981        PMID: 7470846     DOI: 10.1093/brain/104.1.79

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  23 in total

Review 1.  Cerebral magnetic resonance imaging in patients with chronic liver disease.

Authors:  M Y Morgan
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Neuronal cell death in hepatic encephalopathy.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 3.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 4.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

5.  Adult-type citrullinemia.

Authors:  R Okeda; M Tanaka; Y Kawahara; J Tokushige; T Imai; K Kameya
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 6.  Acquired hepatocerebral degeneration: a case report.

Authors:  Wei-Xing Chen; Ping Wang; Sen-Xiang Yan; You-Ming Li; Chao-Hui Yu; Ling-Ling Jiang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

Review 7.  Movement dysfunction and hepatic encephalopathy.

Authors:  G P Layrargues
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

8.  [About a case of cirrhotic alcoholic encephalopathy. Methodological remarks and results].

Authors:  C Fuentès; H Michel; G Roch; R Marty
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

9.  Neuropathology of ornithine carbamyl transferase deficiency.

Authors:  M Kornfeld; B M Woodfin; L Papile; L E Davis; L R Bernard
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

10.  Primary necrosis of corpus callosum with dystrophic astrogliosis and Rosenthal-like fiber formation. The first Chinese case of Marchiafava-Bignami's disease (MBD).

Authors:  K C Ma; K J Chen
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.